Miravo Healthcare™ Presents at the SNN Network Canada Virtual Event
11/24/2021 - 07:30 AM
- Wednesday, December 8th – 11:00 a.m. ET -
MISSISSAUGA, Ontario --(BUSINESS WIRE)--
Nuvo Pharmaceuticals ® Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian focused healthcare company with global reach and a diversified portfolio of commercial products, will be presenting at the SNN Network Canada Virtual Event 2021 on Wednesday, December 8, 2021 at 11:00 a.m. ET . Jesse Ledger , President & Chief Executive Officer and Mary-Jane Burkett , Vice President & Chief Financial Officer of Miravo will be hosting the presentation and answering questions from investors.
To access the live presentation, please use the following information:
SNN Network Canada Virtual Event 2021
Date: Wednesday, December 8, 2021
Time: 11:00 a.m. Eastern Time (8:00 a.m. Pacific Time )
Webcast : https://www.webcaster4.com/Webcast/Page/2813/43693
If you would like to book 1on1 investor meetings with Miravo Healthcare , and to watch Miravo Healthcare’s presentation, please make sure you are registered for the virtual event here: https://canada.snn.network/signup .
1on1 meetings will be scheduled and conducted via private, secure video conference through the conference event platform.
The SNN Network Canada Virtual Event website is available here: https://canada.snn.network/ .
If you can’t make the live presentation, all company presentations “webcasts” will be available directly on the conference event platform on this link under the tab “Agenda”: https://canada.snn.network/agenda .
About Miravo Healthcare
Miravo is a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products. The Company’s products target several therapeutic areas, including pain, allergy, neurology and dermatology. The Company’s strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets. Miravo’s head office is located in Mississauga, Ontario, Canada , the international operations are located in Dublin, Ireland and the Company’s manufacturing facility is located in Varennes, Québec, Canada . The Varennes facility operates in a Good Manufacturing Practices (GMP) environment respecting the U.S , Canada and E.U. GMP regulations and is regularly inspected by Health Canada and the U.S. Food and Drug Administration . For additional information, please visit www.miravohealthcare.com .
About SNN.Network
SNN.Network is your multimedia financial news platform for discovery, transparency and due diligence. This is your one-stop hub to find new investment ideas, check in on watchlist, gather the most up-to-date information on the Small-, Micro-, Nano-Cap market with the goal to help you towards achieving your wealth generation goals. Follow the companies YOU want to know more about; read and watch content from YOUR favorite finance and investing influencers; create YOUR own watchlist and screen for ideas YOU'RE interested in; find out about investor conferences YOU want to attend - all here on SNN Network.
View source version on businesswire.com : https://www.businesswire.com/news/home/20211124005840/en/
Investor Relations
Stefan Eftychiou
905 326 1888 ext 60
stefan@bristolir.com
Source: Nuvo Pharmaceuticals Inc